Treating drug addiction is two-fold: one part is law enforcement reducing the supply and another is getting addicts the help they need to recover.
Such is what legislators heard during a House Republican Policy Committee on Thursday as Pennsylvania continues to deal with an opioid crisis that outpaces the rest of the country.
Read More
Public opinion on the pharmaceutical industry has declined sharply over the past decade, according to new polling released by Gallup.
The proportion of Americans who believe pharmaceutical companies provide good or excellent services declined 21 points between 2010 and 2023, according to a poll released Monday. Public controversies over COVID-19 vaccines and the opioid crisis have implicated the pharmaceutical industry in recent years.
Read More
Medicaid expansion has failed to prevent the ensuing opioid crisis, with 14 out of the 15 states with the highest overdose rates being expansion states, according to research exclusively shared with the Daily Caller News Foundation.
The research from the Foundation for Government Accountability (FGA) indicates that while Medicaid expansion was intended to combat the opioid crisis, it hasn’t helped and “may be making it worse,” co-authors Michael Greibrock and Sam Adolphsen wrote. Of the states with the lowest overdose rates, half of them are non-expansion states, and another two only recently expanded.
Read More
Teva Pharmaceuticals, one of the world’s largest generic drug manufacturer, has reached an agreement in principle to settle all outstanding lawsuits over their alleged involvement in the national opioid crisis for $4.35 billion, according to a Teva press release.
This payout includes a commitment to supply $1.2 billion worth of Narcan, a drug that reverses opioid overdose, over the next ten years, the release states. The $4.25 billion will be distributed over the next 13 years, with $100 million being earmarked for Native American Tribes.
Read More
Researchers are warning that the United States is facing its most significant spike in opioid deaths as patients increasingly mix synthetic pain pills with stimulants such as cocaine and methamphetamines.
Read More
Fifty Pennsylvania counties have joined a historic global opioid settlement that is expected to bring $1 billion to the state to fight the opioid crisis.
The $26 billion settlement involves the nation’s three major pharmaceutical distributors – Cardinal, McKesson and AmerisourceBergen – as well as Johnson & Johnson. The agreement requires industry changes to help prevent a similar crisis in the future, in addition to the funds, Pennsylvania Attorney General Josh Shapiro said.
“Pennsylvania lost 5,172 lives to overdoses in the last year alone, which is 14 Pennsylvanians a day. This settlement is going to provide resources to jumpstart programs that will change lives and impact families across our commonwealth who are struggling to find treatment and help for those struggling with substance abuse,” Shapiro said. “These funds will be earmarked to offer and expand life-saving treatment options, prioritizing the areas that have been most affected by this crisis.”
Read More